TRS Overview

TriMas Corporation designs, manufactures and supplies a range of products for the consumer packaging and industrial markets through its TriMas Packaging and Specialty Products groups. The Company's segments include Packaging and Specialty Products. Its Packaging segment offers dispensing, closure and flexible packaging solutions, including Rieke, Affaba & Ferrari, Taplast, Rapak and Aarts Packaging, along with Intertech and Omega Plastics, which provide life sciences–focused products. Its Packaging business develops and manufactures an array of dispensing products, polymeric and steel caps and closures, polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components, all for a variety of consumer products submarkets. Its Specialty Products segment, which includes the Norris Cylinder business, designs, manufactures and distributes highly engineered steel cylinders.

Wall Street analysts forecast TRS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TRS is41.50 USD with a low forecast of 38.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

TriMas Corp revenue for the last quarter amounts to 168.28M USD, increased 10.38

TriMas Corp. EPS for the last quarter amounts to 21.40 USD, increased 7033.33

TriMas Corp (TRS) has 3700 emplpoyees as of May 18 2026.

Today TRS has the market capitalization of 1.36B USD.